Key Takeaways
- Shares of SPCX declined 4.05% Thursday, retreating beneath the $135 initial public offering price
- A total of 319 million previously restricted shares entered circulation, increasing market supply
- The pullback terminated a six-session period during which the stock had maintained levels above its offering price
- In mid-August, SpaceX finalized a $60 billion all-equity deal for Cursor, introducing approximately 389 million additional Class A shares
- Wall Street consensus stands at Moderate Buy with analysts projecting an average target of $232.35
Shares of SpaceX experienced a 4.05% downturn Thursday, sliding beneath the company’s $135 initial public offering threshold to trade in the $130-$134 range. The setback coincided with the release of 319 million shares from their lockup restriction.
Space Exploration Technologies Corp., SPCX
Thursday’s unlock marked the second major restriction period to conclude following the aerospace company’s June public debut. The freshly available shares account for approximately 7% of SpaceX’s complete share count.
The decline brought an end to six straight trading days where SPCX had finished above its offering price. Additionally, the stock extended its consecutive loss streak to three sessions.
When the first lockup expired on August 6, SpaceX’s publicly tradable shares effectively doubled as 911.5 million shares flooded the market. Surprisingly, the stock climbed 6% during that initial, considerably larger release. Thursday’s comparatively modest unlock produced the inverse result.
The contrasting response reflects shifting market dynamics and heightened dilution worries. With the float having already expanded substantially, investor enthusiasm at prevailing price points proved insufficient.
Cursor Acquisition Compounds Share Dilution
Thursday’s lockup conclusion followed closely on the heels of SpaceX’s August 14 completion of its $60 billion all-equity purchase of AI-powered coding assistant Cursor. The transaction introduced approximately 389 million fresh Class A shares, compounding dilution of the existing float.
The convergence of acquisition-related issuance and lockup expiration means SPCX’s available trading supply has ballooned significantly within a compressed timeframe.
SpaceX has additionally contended with scrutiny over its capital allocation. The corporation’s second-quarter financial disclosure revealed $18.4 billion in capital outlays, unnerving market participants and driving shares down nearly 8% following the announcement.
Earlier, a $25 billion corporate debt issuance in late June sparked a 16% single-session plunge as investors grew concerned about the company’s cash consumption rate.
Additional Share Releases Scheduled Ahead
The lockup timeline continues with more releases planned. November 2026 will bring another 1.3 billion shares to market coinciding with third-quarter results. The complete 180-day post-IPO lockup restriction concludes in December 2026.
Subsequently, June 2027 represents the most substantial supply event when Elon Musk’s holdings of 6.42 billion shares become freely tradable. That final release dwarfs all previous unlocks.
SpaceX executed the largest initial public offering in American market history on June 12, establishing a $135 price point. The equity surged during its inaugural trading week, reaching an all-time peak of $225.64 and momentarily valuing SpaceX above technology giants Microsoft and Amazon.
Since that zenith, shares have retreated to the $130-$140 corridor, touching a post-listing floor of $108.27 fewer than eight weeks after going public.
Notwithstanding the price swings, professional analysts maintain measured confidence. SPCX holds a Moderate Buy consensus derived from 24 Buy recommendations, five Hold ratings, and three Sell opinions among analysts tracking the stock post-IPO.
The mean analyst price objective registers at $232.35, suggesting potential appreciation of approximately 73% from present trading levels.





